These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26177654)

  • 1. Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs.
    Appel NM; Li SH; Holmes TH; Acri JB
    J Pharmacol Exp Ther; 2015 Sep; 354(3):484-92. PubMed ID: 26177654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly Developed Dopamine D
    Jordan CJ; Humburg BA; Thorndike EB; Shaik AB; Xi ZX; Baumann MH; Newman AH; Schindler CW
    J Pharmacol Exp Ther; 2019 Dec; 371(3):602-614. PubMed ID: 31562201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction.
    Xi ZX; Gardner EL
    CNS Drug Rev; 2007; 13(2):240-59. PubMed ID: 17627675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state.
    te Beek ET; Zoethout RW; Bani MS; Andorn A; Iavarone L; Klaassen ES; Fina P; van Gerven JM
    J Psychopharmacol; 2012 Feb; 26(2):303-14. PubMed ID: 22219221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis.
    Newman AH; Blaylock BL; Nader MA; Bergman J; Sibley DR; Skolnick P
    Biochem Pharmacol; 2012 Oct; 84(7):882-90. PubMed ID: 22781742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.
    Murphy A; Nestor LJ; McGonigle J; Paterson L; Boyapati V; Ersche KD; Flechais R; Kuchibatla S; Metastasio A; Orban C; Passetti F; Reed L; Smith D; Suckling J; Taylor E; Robbins TW; Lingford-Hughes A; Nutt DJ; Deakin JF; Elliott R
    Neuropsychopharmacology; 2017 Apr; 42(5):1049-1057. PubMed ID: 28042871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.
    Searle G; Beaver JD; Comley RA; Bani M; Tziortzi A; Slifstein M; Mugnaini M; Griffante C; Wilson AA; Merlo-Pich E; Houle S; Gunn R; Rabiner EA; Laruelle M
    Biol Psychiatry; 2010 Aug; 68(4):392-9. PubMed ID: 20599188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel dopamine D3 receptor antagonist YQA14 inhibits methamphetamine self-administration and relapse to drug-seeking behaviour in rats.
    Chen Y; Song R; Yang RF; Wu N; Li J
    Eur J Pharmacol; 2014 Nov; 743():126-32. PubMed ID: 25261038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats.
    Gál K; Gyertyán I
    Drug Alcohol Depend; 2006 Jan; 81(1):63-70. PubMed ID: 16005579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specific and direct comparison of the trifluoromethyl and pentafluoro sulfanyl groups on the selective dopamine D(3) antagonist 3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-1-phenyl-3-azabicyclo[3.1.0]hexane template.
    Micheli F; Andreotti D; Braggio S; Checchia A
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4566-8. PubMed ID: 20573506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of eticlopride and the selective D3-antagonist PNU 99194-A on food- and cocaine-maintained responding in rhesus monkeys.
    Claytor R; Lile JA; Nader MA
    Pharmacol Biochem Behav; 2006 Mar; 83(3):456-64. PubMed ID: 16631246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective dopamine D₃ receptor antagonist SB-277011A attenuates drug- or food-deprivation reactivation of expression of conditioned place preference for cocaine in male Sprague-Dawley rats.
    Ashby CR; Rice OV; Heidbreder CA; Gardner EL
    Synapse; 2015 Jun; 69(6):336-44. PubMed ID: 25851636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
    Xi ZX; Newman AH; Gilbert JG; Pak AC; Peng XQ; Ashby CR; Gitajn L; Gardner EL
    Neuropsychopharmacology; 2006 Jul; 31(7):1393-405. PubMed ID: 16205781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.
    Paterson NE; Vocci F; Sevak RJ; Wagreich E; London ED
    Am J Drug Alcohol Abuse; 2014 Jan; 40(1):1-9. PubMed ID: 24359505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat.
    Cervo L; Cocco A; Petrella C; Heidbreder CA
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):167-81. PubMed ID: 16426478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dopamine D3 receptors in controlling the expression of cocaine sensitization in rats.
    Filip M; Papla I; Czepiel K
    Pol J Pharmacol; 2002; 54(6):687-91. PubMed ID: 12866725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects.
    Nathan PJ; O'Neill BV; Mogg K; Bradley BP; Beaver J; Bani M; Merlo-Pich E; Fletcher PC; Swirski B; Koch A; Dodds CM; Bullmore ET
    Int J Neuropsychopharmacol; 2012 Mar; 15(2):149-61. PubMed ID: 21745436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo imaging of cerebral dopamine D3 receptors in alcoholism.
    Erritzoe D; Tziortzi A; Bargiela D; Colasanti A; Searle GE; Gunn RN; Beaver JD; Waldman A; Nutt DJ; Bani M; Merlo-Pich E; Rabiner EA; Lingford-Hughes A
    Neuropsychopharmacology; 2014 Jun; 39(7):1703-12. PubMed ID: 24469594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective D3 receptor antagonism modulates neural response during negative emotional processing in substance dependence.
    Vamvakopoulou IA; Fonville L; Hayes A; McGonigle J; Elliott R; Ersche KD; Flechais R; Orban C; Murphy A; Smith DG; Suckling J; Taylor EM; Deakin B; Robbins TW; Nutt DJ; Lingford-Hughes AR; Paterson LM
    Front Psychiatry; 2022; 13():998844. PubMed ID: 36339857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.